EMMA FRIDLINE: Open Payments
NPI 1942875893 · SAGINAW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,332 in 236 payments from 28 companies in 2025. Trend: 2023 $3,177 · 2024 $4,008 · 2025 $4,332
Food & beverage: $3,886Education: $446
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $688 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 25 | $478 |
| Janssen Biotech, Inc. | 11 | $421 |
| GENZYME CORPORATION | 12 | $390 |
| Novartis Pharmaceuticals Corporation | 24 | $309 |
| UCB, Inc. | 13 | $291 |
| E.R. Squibb & Sons, L.L.C. | 22 | $256 |
| Regeneron Healthcare Solutions, Inc. | 7 | $241 |
| Galderma Laboratories, L.P. | 26 | $229 |
| Incyte Corporation | 10 | $182 |
Products named: DUPIXENT, RINVOQ, TREMFYA, ILUMYA, Bimzelx, Sotyktu, COSENTYX, NEMLUVIO.
Industry payments across MI — which companies pay providers there.
